Brief: Evotec H1 Revenue At EUR 371.2 Mln
Aug 13 (Reuters) - EVOTEC SE EVTG.DE: OUTLOOK FY REVENUE EUR 760-800 MILLION OUTLOOK FY ADJUSTED EBITDA EUR 30-50 MILLION COST SAVINGS EXPECTED TO EXCEED TARGETS ANNOUNCED DURING Q1 2025 RESULTS CALL ON 06 MAY 2025 H1 GROUP REVENUES DECREASED BY 5.0% TO EUR 371.2 M H1 ADJUSTED GROUP EBITDA TOTALLED EUR (1.9) M (6M 2024: EUR (0.5) M) H1 REVENUE EUR 371.2 MILLION Source text: ID:nEQ6jpKs7a Further company coverage: EVTG.DE (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on Evotec SE
See all newsEvotec up 7% in early trade after 9-month revenue, earnings beat
Brief: Evotec Says Preliminary Nine-Month 2026 Results Above Market Expectations
Brief: Evotec Initiates Phase 1 Trial For Jst-018 Antibodies Targeting Orthopoxviruses
Brief: EVOTEC Q2 Group Revenues €143.50 Mln
Brief: Evotec And Odyssey Therapeutics Enter AI-Enabled R&D Collaboration In Autoimmune And Inflammatory Diseases